Skip to content
Home » Realtech Holdings invests in Illumi Medical, a startup from Nagoya University that conducts research and development of medical devices for phototherapy.

Realtech Holdings invests in Illumi Medical, a startup from Nagoya University that conducts research and development of medical devices for phototherapy.

Realtech Holdings Co., Ltd.
Realtech Holdings invests in Illumi Medical, a startup from Nagoya University that conducts research and development of medical devices for phototherapy.
……
Real Tech Fund*, managed by Real Tech Holdings Co., Ltd. (Location: Minato-ku, Tokyo; Representatives: Yukihiro Maru and Akihiko Nagata), is a subsidiary of Illumi Medical Co., Ltd., a startup from Nagoya University that conducts research and development of medical devices for phototherapy. (Headquarters: Nagoya City, Aichi Prefecture, President and Representative Director: Toshihiko Tsukamoto,
hereinafter referred to as “Illumi Medical”). Illumi Medical aims to “promote the practical application of treatment technology that uses light and provide effective treatment for patients who were previously unable to receive treatment.” We conduct research and development of medical devices.
[Image: https://prtimes.jp/i/36405/124/resize/d36405-124-c992313fe11a793f244a-0.jpg&s3=36405-124-ef2f4cd65a3622063988eba5f42cee2a-3000×1575.jpg] ■Company overview
Illumi Medical is a startup that has developed ET-BLIT(R)*1, an intravascular light irradiation system that delivers light to target tissues with high selectivity, safety, and efficiency to all parts of the body, including deep internal organs. . Currently, research into the medical application of optical technology is being actively conducted around the world, but although optical therapy is a technology that uses a combination of light and drugs, it is difficult to deliver light to the deep parts of the body. has become an issue. Therefore, at Illumi Medical, we are proceeding with the development of technology that delivers light through blood vessels, and by establishing “technology that enables pinpoint delivery of light anywhere in the body,” we will realize “the provision of new medical care using light.” A startup that makes it possible.
*1 ET-BLIT(R): A technology that performs treatment by irradiating tissue with light emitted from within blood vessels. A registered trademark for endovascular treatment systems owned by Illumi Medical. ■Purpose and use of funding
Illumi Medical won the Real Tech Award at the Gifu Tech Planter held in Gifu in 2023. This time, we received investment from Real Tech Holdings, OKB Capital of the Ogaki Kyoritsu Bank Group, and two other companies, raising a total of 170 million yen. With this funding, we will conduct non-clinical experiments on the intravascular light irradiation device and aim to establish light irradiation technology. ■Comment from person in charge
We believe that the introduction of the light irradiation device developed by Illumi Medical will provide a major advantage by expanding the options for new treatment methods for cancer patients for whom no treatment has been available or for patients who desire less invasive treatment. I also believe that if a treatment method using light proves effective not only for cancer treatment but also for neurological diseases, it will be a huge breakthrough in drug discovery.
(Realtech Holdings Co., Ltd. Growth Manager Hiromi Hiraizumi) *Official name: “Real Tech Fund No. 4 Investment Limited Partnership” ■About Illumi Medical Co., Ltd.
Date of establishment: February 2023
Address: Room 5, Science Plaza, 5-301 Sakurazaka, Moriyama-ku, Nagoya, Aichi Prefecture
Representative: Toshihiko Tsukamoto
Business details: Development of methods and medical devices that can deliver light to the necessary places, mainly deep within the body. Official website: https://illumimedical.com/
Investment period: March 2024
■About Realtech Holdings
Realtech Holdings Co., Ltd. is working to solve social issues through investment and development in deep tech startups that have innovative technology (realtech) that contributes to solving the problems of the earth and humanity.
The venture capital “Real Tech Fund” operated by the company is run by Akihiko Nagata, Representative Executive Officer and CEO of Euglena Co., Ltd., who has experience in leading deep tech startups to success, and has a rich track record of supporting deep tech startups even before they are founded. It was founded by Yukihiro Maru, CEO of Leave a Nest Co., Ltd. To date, we have managed over 27 billion yen and invested in over 95 startups both domestically and
internationally. In 2021, in addition to establishing Japan’s first impact investment fund investing in the deep tech field, we are actively working to promote impact investing as a signatory and steering committee member of the Impact-Oriented Finance Declaration. .
HP: https://www.realtech.holdings
-Contact information-
Realtech Holdings Co., Ltd.
Public relations person: Narita
https://www.realtech.holdings/contact
More details about this release:
https://prtimes.jp/main/html/rd/p/000000124.000036405.html



%d